Balance Sheet Data
Sartorius Stedim Biotech S.A. (DIM.PA)
325.8 €
+7.80 (+2.45%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 45.39 | 43.19 | 45.94 | 69.60 | 237.35 | 169.52 | 218.13 | 280.69 | 361.18 | 464.76 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | - | - | - | - | - | - | - | - |
| Account Receivables (%) | ||||||||||
| Inventories | 185.60 | 252 | 328.16 | 472.31 | 782.95 | 836.49 | 1,076.37 | 1,385.05 | 1,782.24 | 2,293.34 |
| Inventories (%) | ||||||||||
| Accounts Payable | 69.90 | 154.57 | 196.57 | 174.73 | 251.36 | 376.82 | 484.88 | 623.94 | 802.86 | 1,033.10 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -126.83 | -176.54 | -135.97 | -159.19 | -318.07 | -409.28 | -526.65 | -677.68 | -872.02 | -1,122.09 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.